• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊科针对发热幼儿采用新型抗菌药物序贯使用方法的影响评估(DIAFEVERCHILD研究):一项法国前瞻性多中心对照、开放、整群随机、平行组研究方案

Assessment of the impact of a new sequential approach to antimicrobial use in young febrile children in the emergency department (DIAFEVERCHILD): a French prospective multicentric controlled, open, cluster-randomised, parallel-group study protocol.

作者信息

Hubert Gaelle, Launay Elise, Feildel Fournial Cécile, Chauvire-Drouard Anne, Lorton Fleur, Tavernier Elsa, Giraudeau Bruno, Gras Le Guen Christele

机构信息

Paediatrics Emergency Department, CHU Nantes, Nantes, France

General Paediatrics Department, CHU Nantes, Nantes, France.

出版信息

BMJ Open. 2020 Aug 13;10(8):e034828. doi: 10.1136/bmjopen-2019-034828.

DOI:10.1136/bmjopen-2019-034828
PMID:32792425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7430445/
Abstract

INTRODUCTION

Fever is one of the most common reasons for consultation in the paediatric emergency department (ED). Because of fear of bacterial infection in parents and caregivers, clinicians often overprescribe laboratory tests and empirical antibiotic treatment. The aims of this study are to demonstrate that using a procalcitonin (PCT) rapid test-based prediction rule (1) would not be inferior to usual practice in terms of morbidity and mortality (non-inferiority objective) and (2) would result in a significant reduction in antibiotic use (superiority objective).

METHODS AND ANALYSIS

This prospective multicentric cluster-randomised study aims to include 7245 febrile children aged 6 days to 3 years with a diagnosis of fever without source in 26 participating EDs in France and Switzerland during a 24-month period. During first period, all children will receive usual care. In a second period, a point-of-care PCT-based algorithm will be used in half of the clusters. The primary endpoints collected on day 15 after ED consultation will be a composite outcome of death or intensive care unit admission for any reason, disease-specific complications, diagnosis of bacterial infection after discharge from the ED for the non-inferiority objective and proportion of children with antibiotic treatment administered for the superiority objective. The endpoints will be compared between the two groups (experimental and control) by using a mixed logistic regression model adjusted on clustering of participants within centres and period within centres.

DISCUSSION

If the algorithm is validated, a new strategy will be discussed with medical societies to safely manage fever in young children without the need for invasive procedures for microbiological testing or empirical antibiotics.

ETHICS AND DISSEMINATION

This study was submitted to an independent ethics committee on 17 May 2018 (no. 2018-A00252-53). Results will be submitted to international peer-reviewed journals and presented at international conferences.

TRIAL REGISTRATION NUMBER

NCT03607162; Pre-results.

摘要

引言

发热是儿科急诊科(ED)最常见的就诊原因之一。由于家长和护理人员担心细菌感染,临床医生经常过度开具实验室检查和经验性抗生素治疗。本研究的目的是证明,使用基于降钙素原(PCT)快速检测的预测规则:(1)在发病率和死亡率方面(非劣效性目标)不低于常规治疗;(2)将显著减少抗生素的使用(优效性目标)。

方法与分析

这项前瞻性多中心整群随机研究旨在纳入法国和瑞士26个参与研究的急诊科在24个月期间内7245名6天至3岁发热且无明确病因的儿童。在第一阶段,所有儿童将接受常规护理。在第二阶段,一半的整群将使用基于即时检测PCT的算法。在急诊科就诊后第15天收集的主要终点指标,对于非劣效性目标而言,将是因任何原因死亡或入住重症监护病房的综合结局、特定疾病并发症、急诊科出院后细菌感染的诊断;对于优效性目标而言,将是接受抗生素治疗的儿童比例。将通过使用在中心内参与者聚类和中心内时间段上进行调整的混合逻辑回归模型,对两组(实验组和对照组)的终点指标进行比较。

讨论

如果该算法得到验证,将与医学协会讨论一种新的策略,以安全管理幼儿发热,而无需进行微生物检测的侵入性操作或使用经验性抗生素。

伦理与传播

本研究于2018年5月17日提交给独立伦理委员会(编号2018 - A00252 - 53)。结果将提交给国际同行评审期刊,并在国际会议上展示。

试验注册号

NCT03607162;预结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d792/7430445/6e575451b789/bmjopen-2019-034828f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d792/7430445/4dec2ef59256/bmjopen-2019-034828f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d792/7430445/6e575451b789/bmjopen-2019-034828f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d792/7430445/4dec2ef59256/bmjopen-2019-034828f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d792/7430445/6e575451b789/bmjopen-2019-034828f02.jpg

相似文献

1
Assessment of the impact of a new sequential approach to antimicrobial use in young febrile children in the emergency department (DIAFEVERCHILD): a French prospective multicentric controlled, open, cluster-randomised, parallel-group study protocol.急诊科针对发热幼儿采用新型抗菌药物序贯使用方法的影响评估(DIAFEVERCHILD研究):一项法国前瞻性多中心对照、开放、整群随机、平行组研究方案
BMJ Open. 2020 Aug 13;10(8):e034828. doi: 10.1136/bmjopen-2019-034828.
2
PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial.降钙素原和 NEWS2 评估用于急诊科及时识别脓毒症和优化抗生素使用(PRONTO):一项多中心、开放标签、随机对照试验的方案。
BMJ Open. 2022 Jun 13;12(6):e063424. doi: 10.1136/bmjopen-2022-063424.
3
PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial.PLUS-IS-LESS项目:瑞士急诊科下呼吸道感染患者基于降钙素原和肺部超声的抗生素治疗:一项实用阶梯式楔形整群随机试验的研究方案
Trials. 2024 Jan 25;25(1):86. doi: 10.1186/s13063-023-07795-y.
4
Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).降钙素原指导下的抗生素治疗在普通急诊患者发热中的应用:一项多中心非劣效性随机临床试验(HiTEMP 研究)。
Clin Microbiol Infect. 2018 Dec;24(12):1282-1289. doi: 10.1016/j.cmi.2018.05.011. Epub 2018 Jun 2.
5
C reactive protein-guided prescription of antibiotics for children under 12 years with respiratory symptoms in Kyrgyzstan: protocol for a randomised controlled clinical trial with 14 days follow-up.C 反应蛋白指导下的抗生素处方用于治疗吉尔吉斯斯坦 12 岁以下有呼吸系统症状的儿童:一项为期 14 天随访的随机对照临床试验方案。
BMJ Open. 2023 Apr 11;13(4):e066806. doi: 10.1136/bmjopen-2022-066806.
6
A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.一种使用宿主生物标志物即时检验来管理坦桑尼亚儿童发热性疾病的新型电子算法(e-POCT):一项随机对照非劣效性试验。
PLoS Med. 2017 Oct 23;14(10):e1002411. doi: 10.1371/journal.pmed.1002411. eCollection 2017 Oct.
7
Individualised versus standard duration of antibiotic therapy in children with acute uncomplicated febrile urinary tract infection: a study protocol and statistical analysis plan for a multicentre randomised clinical trial.个体化与标准疗程抗生素治疗儿童急性单纯性发热性尿路感染:一项多中心随机临床试验的研究方案和统计分析计划。
BMJ Open. 2023 Jun 9;13(6):e070888. doi: 10.1136/bmjopen-2022-070888.
8
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.降钙素原用于启动或停用急性呼吸道感染患者的抗生素治疗。
Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927.
9
Evaluation of a clinical decision rule to guide antibiotic prescription in children with suspected lower respiratory tract infection in The Netherlands: A stepped-wedge cluster randomised trial.评估临床决策规则以指导荷兰疑似下呼吸道感染儿童使用抗生素:一项 stepped-wedge 集群随机试验。
PLoS Med. 2020 Jan 31;17(1):e1003034. doi: 10.1371/journal.pmed.1003034. eCollection 2020 Jan.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

本文引用的文献

1
Clinical prediction models for young febrile infants at the emergency department: an international validation study.急诊科发热婴幼儿的临床预测模型:一项国际验证研究。
Arch Dis Child. 2018 Nov;103(11):1033-1041. doi: 10.1136/archdischild-2017-314011. Epub 2018 May 24.
2
Outpatient management of children at low risk for bacterial meningitis.儿童低风险细菌性脑膜炎的门诊管理。
Emerg Med J. 2018 Jun;35(6):361-366. doi: 10.1136/emermed-2017-206834. Epub 2018 Mar 21.
3
Procalcitonin and C-reactive protein may help to detect invasive bacterial infections in children who have fever without source.
降钙素原和 C 反应蛋白有助于检测原因不明发热患儿是否存在侵袭性细菌感染。
Acta Paediatr. 2018 Jul;107(7):1262-1269. doi: 10.1111/apa.14248. Epub 2018 Feb 19.
4
Refined Lab-score, a Risk Score Predicting Serious Bacterial Infection in Febrile Children Less Than 3 Years of Age.改良实验室评分,预测 3 岁以下发热儿童严重细菌感染的风险评分。
Pediatr Infect Dis J. 2018 May;37(5):387-393. doi: 10.1097/INF.0000000000001915.
5
Point-of-care Testing in Pediatric Infectious Diseases.儿科传染病的即时检验
Pediatr Infect Dis J. 2018 Jan;37(1):108-110. doi: 10.1097/INF.0000000000001806.
6
The Yale Observation Scale Score and the Risk of Serious Bacterial Infections in Febrile Infants.耶鲁观察量表评分与发热婴儿严重细菌感染风险
Pediatrics. 2017 Jul;140(1). doi: 10.1542/peds.2017-0695. Epub 2017 Jun 6.
7
Predicting Risk of Serious Bacterial Infections in Febrile Children in the Emergency Department.预测急诊科发热儿童严重细菌感染的风险。
Pediatrics. 2017 Aug;140(2). doi: 10.1542/peds.2016-2853. Epub 2017 Jul 5.
8
Biomarker tests for bacterial infection-a costly wait for the holy grail.用于细菌感染的生物标志物检测——等待圣杯的昂贵过程。
Lancet Infect Dis. 2017 Apr;17(4):369-370. doi: 10.1016/S1473-3099(17)30124-X.
9
RNA signature test to distinguish bacterial from viral infection.用于区分细菌感染和病毒感染的RNA特征检测
J Pediatr. 2017 Mar;182:401-404. doi: 10.1016/j.jpeds.2016.12.066.
10
Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger.60日龄及以下发热婴儿中RNA生物标志物与细菌感染的关联
JAMA. 2016;316(8):846-57. doi: 10.1001/jama.2016.9207.